Researcher
Sarah Cappuyns
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Cancer biology
- Disciplines (KU Leuven):Cancer biology
- See also: Sarah Cappuyns (Flanders Institute for Biotechnology)
Affiliations
- Digestive Oncology (Division)
Member
From1 Aug 2022 → Today - Lambrechts Lab (Research group)
Member
From1 Oct 2019 → Today - Clinical Digestive Oncology (Division)
Member
From10 Sep 2019 → Today
Projects
1 - 1 of 1
- The search for biomarkers in systemic treatment of advanced hepatocellular carcinoma.From1 Oct 2019 → 1 Oct 2023Funding: FWO Strategic Basic Research Grant
Publications
1 - 10 of 10
- Critical Appraisal of Guideline Recommendations on Systemic Therapies for Advanced Hepatocellular Carcinoma A Review(2024)
Authors: Sarah Cappuyns
- PD-1- CD45RA+ effector-memory CD8 T cells and CXCL10+ macrophages are associated with response to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma(2023)
Authors: Sarah Cappuyns, Bram Boeckx, Ingrid Arijs, Aurelie Mechels, Baki Topal, Chris Verslype, Diether Lambrechts, Jeroen Dekervel
- The ongoing search for biomarkers of response to systemic therapy in advanced hepatocellular carcinoma.(2023)
Authors: Sarah Cappuyns, Jeroen Dekervel, Eric Van Cutsem, Chris Verslype, Diether Lambrechts
- A pan-cancer single-cell tumor micro-environment atlas predictive of immunotherapy response(2023)
Authors: Sam Vanmassenhove, Pierre Van Mol, Sarah Cappuyns, Liselore Loverix, Hanne Vos, Diether Lambrechts
- Unraveling the Synergy between Atezolizumab and Bevacizumab for the Treatment of Hepatocellular Carcinoma(2023)
Authors: Lisa Kinget, Sarah Cappuyns, Chris Verslype, Benoit Beuselinck, Jeroen Dekervel
- Pretreatment immune cell composition and checkpoint ligand expression define the response to immunotherapy in advanced HCC: a study using single-cell sequencing(2022)
Authors: Sarah Cappuyns, Chris Verslype, Diether Lambrechts
- Pretreatment immune cell composition and checkpoint ligand expression define the response to immunotherapy in advanced HCC: a study using single-cell sequencing(2022)
Authors: Sarah Cappuyns, Chris Verslype, Diether Lambrechts
- Combination Therapies for Advanced Hepatocellular Carcinoma: Biomarkers and Unmet Needs(2022)
Authors: Sarah Cappuyns
Pages: 3405 - 3407 - Case report: Two sisters with light-chain cardiac amyloidosis, a mere coincidence?(2022)
Authors: Sarah Cappuyns, Alexander Van De Bruaene, Jan Bogaert, Lucienne Michaux, Michel Delforge
- DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancer(2020)
Authors: Eva Galle, Bernard Thienpont, Sarah Cappuyns, Tom Venken, Pieter Busschaert, Matthias Van Haele, Tania Roskams, Jos van Pelt, Chris Verslype, Jeroen Dekervel, et al.